CVS Health Extends Cardinal Health and McKesson Drug Distribution Deals Through 2032

Simply Wall St··US·Read original
2▲3 ▼0Impact / 5
Summary · why it matters

CVS Health has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management said the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The company said the extension lines up with its focus on more predictable pharmacy and PBM economics, supporting its shift toward cost-based reimbursement models such as CVS CostVantage and its goal of earning a fair margin on every script. It also underpins newer pharmacy-focused outlets opening in 2026 by helping secure supply for those smaller locations. The unresolved piece, the company said, is how pharmacy volume and profitability will track against membership trends and 340B pressure, with the next few quarterly updates through 2027 serving as a checkpoint on script counts, Caremark client retention and management's commentary on 340B headwinds.

Impact on assets 3

Health Care▲
CVS Health Corp
CVS
▲ PositiveSupplyrelevance

CVS locked in drug distribution supply through 2032 with Cardinal and McKesson, supporting its pharmacies and cost-based reimbursement shift.

Cardinal Health Inc
CAH
▲ PositiveDemandrelevance

CVS extended its pharmaceutical distribution agreement with Cardinal Health through 2032, securing a major long-term customer.

McKesson Corporation
MCK
▲ PositiveDemandrelevance

CVS extended its pharmaceutical distribution agreement with McKesson through 2032, keeping a major long-term customer.